Internalising Behaviors in Children Exposed in Utero to Psychotropic Medications
This study examined internalising behaviours in children prenatally exposed to psychotropic medications. A total of 69 new and expectant mothers were recruited in Vancouver, Canada, between 1997 and 1999, including 46 pregnant women diagnosed with depression or anxiety who were treated with psychotropic medications (exposed group), and 23 healthy postpartum women (comparison group). The exposed group was enrolled via the Reproductive Mental Health Program at British Columbia Women’s Hospital, while the comparison group was recruited after delivery from paediatricians’ offices. Participants were assessed at baseline during pregnancy (the exposed group) or shortly after birth (the comparison group). Of the exposed pregnancies, 22 mother–child dyads were followed up, along with 14 dyads from the healthy group. Follow-ups occurred at birth, 3 months, 8 months, and 4–5 years.
Study design
Cohort, Cohort - birth, Cohort - primary caregiver and child, Cohort - clinical
Number of participants at first data collection
69 (mothers)
36 (children)
Age at first data collection
Varied (mothers)
Birth (children)
Participant year of birth
Varied (mothers)
Varied (children)
Participant sex
All
Representative sample at baseline?
No
Sample features
Country
Year of first data collection
1997
Primary Institutions
University of British Columbia (UBC)
Profile paper DOI
Funders
British Columbia Medical Services Foundation
GlaxoSmithKline (GSK)
Ongoing?
No
Data types collected
- Self-report questionnaire – paper or computer assisted
- None
- None
- None
Engagement
Keywords
